Axsome Therapeutics, Inc.
AXSM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001579428
Insider trades, last 90 days
0 buys · 3 sells
- Sold $24.56M
- Open-market purchases (P) and sales (S), counted by Form 4 filing.
13F holders, Q2 2026
505
- +95 vs. Q1 2026
- Total value $9.77B
Superinvestors holding AXSM
0
- None of the superinvestors held AXSM at the end of Q2 2026.
Price chart
Latest insider trades
View all: Latest insider tradesOpen-market purchases and sales by AXSM insiders, newest first.
| Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Sep 3, 20267:09 PM ET | Sep 3, 2026 | Jacobson Mark L.Chief Operating Officer | SSaleCommon Stock | −10K | $208.65 | −$2.09M | 0 | −100.0% | SEC10b5-1 |
| Aug 7, 20267:00 PM ET | Aug 5 – Aug 6, 2026 | TABUTEAU HERRIOTChief Executive Officer | SSaleCommon Stock | −49.66K | $212.192 | −$10.54M | 7.23K | −87.3% | SEC10b5-1 |
| Jul 1, 20267:30 PM ET | Jul 1, 2026 | TABUTEAU HERRIOTChief Executive Officer | SSaleCommon Stock | −49.67K | $240.25 | −$11.93M | 7.23K | −87.3% | SEC10b5-1 |
| Jun 11, 2026 | Jun 10 – Jun 11, 2026 | JEFFS ROGERDirector | SSaleCommon Stock | −572 | $247.65 | −$141.66K | 58.37K | −1.0% | SEC10b5-1 |
| Jun 10, 2026 | Jun 9 – Jun 10, 2026 | Mahony SusanDirector | SSaleCommon Stock | −600 | $241.695 | −$145.02K | 829 | −42.0% | SEC10b5-1 |
Top 5 13F holders, Q2 2026
View all: Top 5 13F holders, Q2 2026The largest institutional positions in AXSM at the end of Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 3,103,708 | $759.69M | 0.01% | −809,136−20.7% | Reduced |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1,983,514 | $485.5M | 0.02% | −74,656−3.6% | Reduced |
| VANGUARD CAPITAL MANAGEMENT LLC | 1,965,086 | $480.99M | 0.01% | +27,334+1.4% | Added |
| Invesco Ltd. | 1,671,684 | $409.18M | 0.03% | +374,006+28.8% | Added |
| FMR LLC | 1,539,163 | $376.74M | 0.02% | −27,832−1.8% | Reduced |